Lysosomal Cholesterol Hydrolysis Couples Efferocytosis to Anti-Inflammatory Oxysterol Production
Open accessThe DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Abstract
Rationale: Macrophages face a substantial amount of cholesterol after the ingestion of apoptotic cells, and the LIPA (lysosomal acid lipase) has a major role in hydrolyzing cholesteryl esters in the endocytic compartment. Objective: Here, we directly investigated the role of LIPA-mediated clearance of apoptotic cells both in vitro and in vivo. Methods and Results: We show that LIPA inhibition causes a defective efferocytic response because of impaired generation of 25-hydroxycholesterol and 27-hydroxycholesterol. Reduced synthesis of 25-hydroxycholesterol after LIPA inhibition contributed to defective mitochondria-associated membrane leading to mitochondrial oxidative stress–induced NLRP3 (NOD-like receptor family, pyrin domain containing) inflammasome activation and caspase-1–dependent Rac1 (Ras-related C3 botulinum toxin substrate 1) degradation. A secondary event consisting of failure to appropriately activate liver X receptor–mediated pathways led to mitigation of cholesterol efflux and apoptotic cell clearance. In mice, LIPA inhibition caused defective clearance of apoptotic lymphocytes and stressed erythrocytes by hepatic and splenic macrophages, culminating in splenomegaly and splenic iron accumulation under hypercholesterolemia. Conclusions: Our findings position lysosomal cholesterol hydrolysis as a critical process that prevents metabolic inflammation by enabling efficient macrophage apoptotic cell clearance.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A role for mitochondria in nlrp3 inflammasome activation
Zhou, R., Yazdi, A. S., Menu, P., & Tschopp, J. (2011) · Nature · doi:10.1038/nature09663 · Cited by 5,602
Macrophage biology in development, homeostasis and disease
Wynn, T. A., Chawla, A., & Pollard, J. W. (2013) · Nature · doi:10.1038/nature12034 · Cited by 4,684 · cited 2×
“First, the dual role of LIPA for optimal alternative macrophage activation,(14) and efferocytosis, as detailed in the present study, might be interconnected in vivo to promote tissue repair and metabolic homeostasis.(1) The findings of reduced LIPA activity in classically activated macrophages and enhanced inflammasom…”
BackgroundNLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals
Duewell, P., Kono, H., Rayner, K. J., Sirois, C. M., Vladimer, G., Bauernfeind, F. G., Abela, G. S., Franchi, L., Nuñez, G., Schnurr, M., et al. (2010) · Nature · doi:10.1038/nature08938 · Cited by 4,026
TFEB Links Autophagy to Lysosomal Biogenesis
Settembre, C., Di Malta, C., Polito, V. A., Arencibia, M. G., Vetrini, F., Erdin, S., Erdin, S. U., Huynh, T., Medina, D., Colella, P., et al. (2011) · Science · doi:10.1126/science.1204592 · Cited by 3,365 · cited 1×
“The dephosphorylated form of TFEB (transcription factor E-box) is essential for optimal TFEB activation through translocation into the nucleus and subsequent activation of a gene network regulating lysosomal biogenesis and autophagy.(22) Inhibition of LIPA in macrophages led to an increase in the dephosphorylated form…”
BackgroundCalcium, ATP, and ROS: a mitochondrial love-hate triangle
Brookes, P. S., Yoon, Y., Robotham, J. L., Anders, M. W., & Sheu, S.-S. (2004) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00139.2004 · Cited by 2,575
Cholesterol, inflammation and innate immunity.
Tall, A. R., & Yvan-Charvet, L. (2015) · Nature Reviews Immunology · doi:10.1038/nri3793 · Cited by 1,479
Self-citationMacrophage death and defective inflammation resolution in atherosclerosis
Tabas, I. (2010) · Nature Reviews Immunology · doi:10.1038/nri2675 · Cited by 1,120
Liver X receptors as integrators of metabolic and inflammatory signaling
Zelcer, N. (2006) · Journal of Clinical Investigation · doi:10.1172/jci27883 · Cited by 978 · cited 1×
“The efflux of cholesterol is governed by liver X receptors (LXRs), which are members of the nuclear receptor superfamily that not only sense an excess of cholesterol but also regulate genes involved in anti-inflammatory responses.(7,10)”
BackgroundSheedy, F. J., Grebe, A., Rayner, K. J., Kalantari, P., Ramkhelawon, B., Carpenter, S. B., Becker, C. E., Ediriweera, H. N., Mullick, A. E., Golenbock, D. T., et al. (2013) · Nature Immunology · doi:10.1038/ni.2639 · Cited by 935
Autophagy Regulates Cholesterol Efflux from Macrophage Foam Cells via Lysosomal Acid Lipase
Ouimet, M., Franklin, V., Mak, E., Liao, X., Tabas, I., & Marcel, Y. L. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2011.03.023 · Cited by 774 · cited 1×
“rials on CD36 scavenger receptor–mediated endocytosis to promote mitochondrial fatty acid oxidation(14) but also cholesteryl esters on the fusion of lipid droplets with lysosomes to support free cholesterol efflux, a process termed lipophagy.(15) This illustrates the pivotal role of LIPA at the interface of”
Background
Research works printed but not linked: 30
- 10.1016/j.cell.2011.12.006 · DOI · Paper page
- 10.1016/j.cell.2010.02.014 · DOI · Paper page
- 10.1038/nature04399 · DOI · Paper page
- 10.1016/j.cell.2005.12.022 · DOI · Paper page
- 10.1038/ni.2681 · DOI · Paper page
- 10.1016/j.jhep.2013.02.014 · DOI · Paper page
- 10.1097/00041433-200410000-00007 · DOI
- 10.2353/ajpath.2006.051327 · DOI
- 10.1038/ni.2956 · DOI · Paper page
- 10.1161/ATVBAHA.114.303342 · DOI · Paper page
- 10.1146/annurev.me.18.020167.000525 · DOI · Paper page
- 10.1038/548534a · DOI
- 10.1038/ni.2595 · DOI · Paper page
- 10.1016/j.devcel.2016.06.029 · DOI · Paper page
- 10.1038/366591a0 · DOI · Paper page
- 10.1016/j.it.2014.02.007 · DOI · Paper page
- 10.1038/nm.1876 · DOI · Paper page
- 10.1016/j.molcel.2009.10.021 · DOI · Paper page
- 10.1038/ncomms1735 · DOI · Paper page
- 10.1126/sciadv.1602038 · DOI · Paper page
- 10.1016/j.immuni.2009.06.018 · DOI · Paper page
- 10.1016/j.cell.2014.04.043 · DOI · Paper page
- 10.1016/j.celrep.2015.08.068 · DOI · Paper page
- 10.1161/01.ATV.19.8.1891 · DOI · Paper page
- 10.1016/j.devcel.2013.09.016 · DOI
- 10.1074/jbc.M302588200 · DOI · Paper page
- 10.1172/JCI32561 · DOI · Paper page
- 10.1001/archinte.1983.00350070037004 · doi:10.1001/archinte.1983.00350070037004
- 10.1161/CIRCGENETICS.110.958728 · DOI · Paper page
- 10.1161/ATVBAHA.116.308734 · DOI
Cited by
Efferocytosis in health and disease
Doran, A. C., Yurdagul, A., & Tabas, I. (2020) · Nature Reviews Immunology · doi:10.1038/s41577-019-0240-6 · Cited by 1,066
Drugging the efferocytosis process: concepts and opportunities
Mehrotra, P., & Ravichandran, K. S. (2022) · Nature Reviews Drug Discovery · doi:10.1038/s41573-022-00470-y · Cited by 459
Phagocytosis of Apoptotic Cells in Resolution of Inflammation
Kourtzelis, I., Hajishengallis, G., & Chavakis, T. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00553 · Cited by 300
Microglial efferocytosis: Diving into the Alzheimer’s disease gene pool
Romero-Molina, C., Garretti, F., Andrews, S. J., Marcora, E., & Goate, A. M. (2022) · Neuron · doi:10.1016/j.neuron.2022.10.015 · Cited by 111
Cholesterol metabolism: from lipidomics to immunology
Griffiths, W. J., & Wang, Y. (2022) · Journal of Lipid Research · doi:10.1016/j.jlr.2021.100165 · Cited by 68
Metadata
- Authors
- Viaud, M., Ivanov, S., Vujic, N., Duta-Mare, M., Aira, L.-E., Barouillet, T., Garcia, E., Orange, F., Dugail, I., Hainault, I., Stehlik, C., Marchetti, S., Boyer, L., Guinamard, R., Foufelle, F., Bochem, A., Hovingh, K. G., Thorp, E. B., Gautier, E. L., Kratky, D., Dasilva-Jardine, P., & Yvan-Charvet, L.
- Venue
- Circulation Research
- Published
- 2018-05-11
- Volume
- 122
- Issue
- 10
- Pages
- 1369-1384
- ISSN
- 0009-7330 (ISSN-L)
- 1524-4571
- OpenAlex
- W2792980100
- Cited by
- 139
- References
- 22
- FWCI
- 4.88
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Lysosomal Cholesterol Hydrolysis Couples Efferocytosis to Anti-Inflammatory Oxysterol Production. https://app.cochat.ai/papers/10.1161/circresaha.117.312333
- The paper
- Viaud, M., Ivanov, S., Vujic, N., Duta-Mare, M., Aira, L.-E., Barouillet, T., Garcia, E., Orange, F., Dugail, I., Hainault, I., Stehlik, C., Marchetti, S., Boyer, L., Guinamard, R., Foufelle, F., Bochem, A., Hovingh, K. G., Thorp, E. B., Gautier, E. L., . . . Yvan-Charvet, L. (2018). Lysosomal Cholesterol Hydrolysis Couples Efferocytosis to Anti-Inflammatory Oxysterol Production. Circulation Research. https://doi.org/10.1161/circresaha.117.312333
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.